Panama - English - Ministerio de Salud (Dirección Nacional de Farmacia Y Drogas)

tecnoquÍmicas, s.a - doxiciclina (hiclato) - doxiciclina (hiclato)....100.000 mg.

Panama - English - Ministerio de Salud (Dirección Nacional de Farmacia Y Drogas)

laboratorios la sante s.a. - doxiciclina (hiclato) - doxiciclina (hiclato)....100 mg

Panama - English - Ministerio de Salud (Dirección Nacional de Farmacia Y Drogas)

beximco pharmaceuticals ltd - doxiciclina (hiclato) - doxiciclina (hiclato)....100 mg

Armenia - English - Դեղերի և բժշկական տեխնոլոգիաների փորձագիտական կենտրոնի գործունեության Հայաստանի Հանրապետությունում

artesan pharma gmbh & co. kg - doxycycline (doxycycline hyclate) - tablets - 100mg

Armenia - English - Դեղերի և բժշկական տեխնոլոգիաների փորձագիտական կենտրոնի գործունեության Հայաստանի Հանրապետությունում

artesan pharma gmbh & co. kg - doxycycline (doxycycline hyclate) - tablets - 100mg

Panama - English - Ministerio de Salud (Dirección Nacional de Farmacia Y Drogas)

apotex inc. - doxiciclina (hiclato) - doxiciclina (hiclato)....100.00 mg

Panama - English - Ministerio de Salud (Dirección Nacional de Farmacia Y Drogas)

eurofarma guatemala, s.a. - doxiciclina (hiclato) - doxiciclina (hiclato)....100.00 mg

Panama - English - Ministerio de Salud (Dirección Nacional de Farmacia Y Drogas)

lmg-bio inc. - doxiciclina (hiclato) - doxiciclina (hiclato)....100 mg

United States - English - NLM (National Library of Medicine)

aphena pharma solutions (formerly testpak) - doxycycline hyclate (unii: 19xts3t51u) (doxycycline anhydrous - unii:334895s862) - doxycycline hyclate 100 mg - to reduce the development of drug-resistant bacteria and maintain effectiveness of doxycycline hyclate and other antibacterial drugs, doxycycline hyclate should be used only to treat or prevent infections that are proven or strongly suspected to be caused by susceptible bacteria. when culture and susceptibility information are available, they should be considered in selecting or modifying antibacterial therapy. in the absence of such data, local epidemiology and susceptibility patterns may contribute to the empiric selection of therapy. doxycycline is indicated for the treatment of the following infections: - rocky mountain spotted fever, typhus fever and the typhus group, q fever, rickettsialpox, and tick fevers caused by rickettsiae. - respiratory tract infections caused by mycoplasma pneumoniae . - lymphogranuloma venereum caused by chlamydia trachomatis . - psittacosis (ornithosis) caused by chlamydia psittaci . - trachoma caused by chlamydia trachomatis , although the infectious agent is not always elimi

United States - English - NLM (National Library of Medicine)

apothecary shop wholesale inc. - doxycycline hyclate (unii: 19xts3t51u) (doxycycline anhydrous - unii:334895s862) - doxycycline hyclate 100 mg - to reduce the development of drug-resistant bacteria and maintain effectiveness of doxycycline hyclate and other antibacterial drugs, doxycycline hyclate should be used only to treat or prevent infections that are proven or strongly suspected to be caused by susceptible bacteria. when culture and susceptibility information are available, they should be considered in selecting or modifying antibacterial therapy. in the absence of such data, local epidemiology and susceptibility patterns may contribute to the empiric selection of therapy. doxycycline is indicated for the treatment of the following infections: -  rocky mountain spotted fever, typhus fever and the typhus group, q. fever, rickettsialpox, and tick fevers caused by rickettsiae. -  respiratory tract infections caused by mycoplasma pneumoniae. -  lymphogranuloma venereum caused by chlamydia trachomatis. -  psittacosis (ornithosis) caused by chlamydia psittaci. -  trachoma caused by chlamydia trachomatis, although the infectious agent is not always el